Trial intelligence / Profile preview

Phase 2 open-label single-arm study of INCB054828 in FGFR2-altered advanced cholangiocarcinoma after prior therapy failure

MOH_2017-06-13_000244Phase 2Not yet recruiting

Sponsor

Incyte

Start

Dec 2016

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1